MedVector (2024)

MedVector (2024)

About this raise

MedVector, with a valuation of $25 million, is raising funds on StartEngine. It is a telemedicine platform that aims to accelerate clinical trials. MedVector’s platform connects subjects from across the world to clinical trial sites and increases participation in clinical trials. The platform is actively working with 20 clinical trial sites and is the official partner of the State of Delaware’s Health Information Network for clinical research. Scott Stout founded MedVector in December 2017. The current crowdfunding campaign has a minimum target of $15,000 and a maximum target of $618,000. The campaign proceeds will be used for marketing, company employment, operations, research and development, and inventory.

Expand

Investment Overview

Invested this round: $126,458

Deal Terms

Total Commitments

Platform
StartEngine
Start Date
05/22/2024
Close Date
08/19/2024
Min. Goal
$15,000
Max Goal
$618,000
Min. Investment

$500

Security Type

Convertible Note

Company Stage

Early Stage

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$25,000,000

Discount

12%

Company & Team

Company

Year Founded
2017
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
Low
Location
El Segundo, California
Business Type
Growth
Company Website
Visit Website

Team

Employees
3
Prior Founder Exits?
No
Founder Name
Scott Stout
Title
CEO
Founder Name
Ted Barduson
Title
COO
Founder Name
Dennis Patterson
Title
SVP Physician Relations and Advisor

Financials

 Revenue
$0
as of FY2023
 Monthly Burn
$75,000
as of FY2023
 Runway
0.4 months
as of

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-704,633

$-653,737

Summary Balance Sheet

FY 2023 FY 2022

Cash

$64,386

$430,542

Accounts Receivable

$0

$0

Total Assets

$411,528

$759,063

Short-Term Debt

$392,239

$360,140

Long-Term Debt

$0

$0

Total Liabilities

$392,239

$360,140

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$2,327,382
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
08/19/2024 StartEngine $25,000,000 $126,458 Convertible Note Funded RegCF
07/29/2021 StartEngine $10,000,000 $906,238 Equity - Common Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
MedVector on StartEngine 2024
Platform: StartEngine
Security Type: Convertible Note
Valuation: $25,000,000

Follow company

Follow MedVector on StartEngine 2024

Buy MedVector's Deal Report

Warning: according to the close date for this deal, MedVector may no longer be accepting investments.

MedVector Deal Report

Get Kingscrowd's comprehensive report on MedVector including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether MedVector is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the MedVector deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge